Insider Deck research · Earnings

ABT earnings · Abbott Laboratories

Abbott Laboratories (ABT) earnings history, EPS vs consensus, beat rate, forward estimates, and transcripts on Insider Deck. Latest print Q2 '26: EPS $1.31 vs consensus $1.28. Beat rate 100% across 4 prints. Next listed date 2026-10-14.

Latest EPS$1.31+0.0% surprise

Beat rate100%4 print streak

Avg surprise+0.0%vs consensus

Next printOct 14, 2026EPS $1.42

Quarterly EPS vs consensus

4 quarters

Actual ConsensusLabels: beat $ · YoY %Revisions 50 up / 16 down

Earnings transcripts

Read management commentary and analyst Q&A.

No transcript dates are available yet for this ticker.

Forward estimates

Consensus expectations and estimate momentum.

PeriodEPSRevenueGrowth

0QSep 2026

$1.42$13.0B+9.2%

+1QDec 2026

$1.64$13.5B+9.2%

0YDec 2026

$5.52$50.3B+7.1%

+1YDec 2027

$6.06$54.6B+9.9%

Primary research

Recent company filings

Jump directly to earnings releases, quarterly reports, and material updates.

Frequently asked questions

When is the next ABT earnings date?

The next listed earnings date for ABT is 2026-10-14. Dates can move — confirm on the earnings desk.

What is ABT's earnings beat rate?

ABT has beaten consensus on roughly 100% of recent prints in the Insider Deck sample.

Where are ABT earnings call transcripts?

Ready transcripts appear under ABT earnings as /stocks/us/abt/earnings/{year}/q{n}.

Where can I research ABT on Insider Deck?

Abbott Laboratories (ABT) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.